Table 2.
General clinical features of mitochondrial diabetes
| Mitochondrial diabetes (n = 15) | |
|---|---|
| Age (year) | 35.0 ± 14.6 |
| Gender (F/M) | 12:3 |
| Disease Duration (year) | 4.00 ± 2.54 |
| BMI (kg/m2) | 19.5 ± 2.36 |
| HbA1c (%) | 6.42 ± 1.01 |
| Fasting blood glucose (mmol/L) | 7.75 ± 2.03 |
| Fasting insulin (μIU/ml) | 5.23 ± 3.26 |
| Fasting C-peptide (ng/ml) | 0.53 ± 0.37 |
| HOMA-IR | 1.63 ± 0.81 |
| HOMA-IS | 0.03 ± 0.02 |
| Diabetes treatment | 7:8 |
| (Insulin: oral hypoglycemic medication) | (5 probands all received insulin therapy) |
BMI body mass index, HOMA-IR fasting plasma glucose (mmol/L) *fasting insulin (μIU/ml)/22.5, HOMA-IS 1/fasting plasma glucose (mmol/L) *fasting insulin (μIU/ml)